Company Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide.
The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.
products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.
It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues.
It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups.
The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015.
Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
| Country | United States |
| Founded | 1927 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 18,000 |
| CEO | Bryan C. Hanson |
Contact Details
Address: 345 East Main Street Warsaw, Indiana 46580 United States | |
| Phone | (574) 267-6131 |
| Website | zimmerbiomet.com |
Stock Details
| Ticker Symbol | ZBH |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001136869 |
| CUSIP Number | 98956P102 |
| ISIN Number | US98956P1021 |
| Employer ID | 13-4151777 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Ivan Tornos | Chief Operating Officer, President, Chief Executive Officer and Director |
| Suketu P. Upadhyay | Chief Financial Officer and Executive Vice President of Finance, Operations and Supply Chain |
| Chad F. Phipps | Senior Vice President, General Counsel and Secretary |
| Sang Yi | President of Asia Pacific |
| Wilfred van Zuilen | Group President of Europe, Middle East and Africa |
| Paul A. Stellato | Vice President, Controller and Chief Accounting Officer |
| Dr. Nitin Goyal M.D. | Chief Science, Technology and Innovation Officer |
| Zeeshan Tariq | Senior Vice President and Chief Information Officer |
| Keri P. Mattox | SVice President and Chief Communications and Administration Officer |
| Zachary Ross Weiner CPA | Director of Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 27, 2024 | ARS | Filing |
| Mar 27, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 27, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 7, 2024 | 144 | Filing |
| Feb 23, 2024 | 10-K | Annual Report |
| Feb 22, 2024 | 144 | Filing |
| Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 13, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Feb 8, 2024 | 8-K | Current Report |